Answers are grounded in this paper and cite their sources.
The first optically active cyclopentadienyl-phosphine bidentate ligands ([Cp-P]H ligands) in which a diphenylphosphino group and a cyclopentadienyl or an indenyl group are connected by an L-threitol derivative or an (S,S)-trans-1,2-dimethylenecyclo-pentane group have been prepared. The rhodium and ruthenium complexes of their anions have been prepared and characterized.
No takes yet. Share an insight, caveat, or question.
Kataoka et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: